Ligand Pharmaceuticals Incorporated (FRA:LGDN)
161.00
-4.00 (-2.42%)
At close: Dec 4, 2025
41.23% (1Y)
| Market Cap | 3.13B |
| Revenue (ttm) | 214.13M |
| Net Income (ttm) | 41.41M |
| Shares Out | n/a |
| EPS (ttm) | 2.12 |
| PE Ratio | 75.54 |
| Forward PE | 27.05 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | n/a |
| Open | 164.00 |
| Previous Close | 165.00 |
| Day's Range | 161.00 - 164.00 |
| 52-Week Range | 86.00 - 181.00 |
| Beta | n/a |
| RSI | 37.25 |
| Earnings Date | Feb 11, 2026 |